THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

James George to Antibodies, Monoclonal, Murine-Derived

This is a "connection" page, showing publications James George has written about Antibodies, Monoclonal, Murine-Derived.
  1. The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura. Blood. 2015 Mar 05; 125(10):1526-31.
    View in: PubMed
    Score: 0.480
  2. Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura. Am J Hematol. 2012 May; 87 Suppl 1:S88-91.
    View in: PubMed
    Score: 0.394
  3. Bone marrow necrosis discovered in a patient with suspected thrombotic thrombocytopenic purpura. Am J Hematol. 2015 Mar; 90(3):264-6.
    View in: PubMed
    Score: 0.118
  4. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer. 2013 Oct; 60(10):1676-82.
    View in: PubMed
    Score: 0.107
  5. Sequence of treatments for adults with primary immune thrombocytopenia. Am J Hematol. 2012 May; 87 Suppl 1:S12-5.
    View in: PubMed
    Score: 0.098
  6. Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes. Hematology Am Soc Hematol Educ Program. 2012; 2012:604-9.
    View in: PubMed
    Score: 0.097
  7. Thrombotic thrombocytopenic purpura: 2008 update. Cleve Clin J Med. 2008 May; 75(5):369-75.
    View in: PubMed
    Score: 0.075
  8. Management of patients with refractory immune thrombocytopenic purpura. J Thromb Haemost. 2006 Aug; 4(8):1664-72.
    View in: PubMed
    Score: 0.067
  9. Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders. J Clin Apher. 2006 Apr; 21(1):49-56.
    View in: PubMed
    Score: 0.065
  10. Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura. Int J Hematol. 2005 Feb; 81(2):119-25.
    View in: PubMed
    Score: 0.060
  11. Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community. Ann Intern Med. 2003 Jan 21; 138(2):152-3.
    View in: PubMed
    Score: 0.052
  12. Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists. Am J Med Sci. 2014 Mar; 347(3):190-4.
    View in: PubMed
    Score: 0.028
  13. Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion. 2012 Dec; 52(12):2525-32; quiz 2524.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES